The importance of patient engagement in the multimodal treatment of MASLD
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is often regarded in society as a disease caused by personal lifestyle and dietary choices. Healthcare providers who have empathy and are able to explain the disease trajectory can better engage with people with MASLD and acti...
Saved in:
| Main Authors: | Joost Boeckmans, Hannes Hagström, Donna R. Cryer, Jörn M. Schattenberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-025-00871-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The weight of choices: Prioritizing lifestyle over GLP-1 receptor agonist therapy in managing MASLD
by: Jörn M. Schattenberg, et al.
Published: (2025-07-01) -
Thyroid dysfunction in MASLD: Results of a nationwide study
by: Shuai Yuan, et al.
Published: (2025-05-01) -
A social media listening study of patients’ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study
by: Jeffrey V. Lazarus, et al.
Published: (2025-01-01) -
Macrophages clear out necrotic liver lesions: a new magic trick revealed
by: Robim M Rodrigues, et al.
Published: (2023-10-01) -
Pharmacotherapeutic perspectives on nutraceuticals in the treatment of MASLD and MASH
by: Ali H. Eid, et al.
Published: (2025-05-01)